{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:44:38Z","timestamp":1782996278366,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.jneuroim.2012.03.018","type":"journal-article","created":{"date-parts":[[2012,4,13]],"date-time":"2012-04-13T09:31:49Z","timestamp":1334309509000},"page":"81-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["HLA-DQA1*03:02\/DQB1*03:03:02 is strongly associated with susceptibility to childhood-onset ocular myasthenia gravis in Southern Han Chinese"],"prefix":"10.1016","volume":"247","author":[{"given":"Wen-Hua","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Hong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Ying","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Shan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Guo","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-Zhen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong-Bo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2012.03.018_bb0005","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/jnnp.56.4.382","article-title":"Association of HLA-Bw46DR9 combination with juvenile myasthenia gravis in Chinese","volume":"56","author":"Chen","year":"1993","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0010","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1744-313X.1987.tb00382.x","article-title":"Association of HLA-DRw9 with myasthenia gravis in Chinese","volume":"14","author":"Chiu","year":"1987","journal-title":"J. Immunogenet."},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0015","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/brain\/103.3.579","article-title":"Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis","volume":"103","author":"Compston","year":"1980","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0025","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/08916930600738581","article-title":"Subtle differences in HLA DQ haplotype-associated presentation of AChR alpha-chain peptides may suffice to mediate myasthenia gravis","volume":"39","author":"Deitiker","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1744-313X.2010.00979.x","article-title":"Association with HLA DQ of early onset myasthenia gravis in Southeast Texas region of the United States","volume":"38","author":"Deitiker","year":"2011","journal-title":"Int. J. Immunogenet."},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1399-0039.2005.00445.x","article-title":"HLA-DQB1 sequencing-based typing using newly identified conserved nucleotide sequences in introns 1 and 2","volume":"66","author":"Dunn","year":"2005","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0035","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/WCO.0b013e32833c32af","article-title":"Acquired myasthenia gravis in childhood","volume":"23","author":"Evoli","year":"2010","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/117693430500100003","article-title":"Arlequin (version 3.0): an integrated software package for population genetics data analysis","volume":"1","author":"Excoffier","year":"2005","journal-title":"Evol. Bioinform. Online"},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0045","first-page":"253","article-title":"Susceptibility alleles and haplotypes of human leukocyte antigen DRB1, DQA1, and DQB1 in autoimmune polyglandular syndrome type III in Japanese population","volume":"64","author":"Hashimoto","year":"2005","journal-title":"Horm. Res."},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0050","first-page":"235","article-title":"Possible evidence for a variant of myasthenia gravis based on HLA and acetylcholine receptor antibody in Chinese patients","volume":"70","author":"Hawkins","year":"1989","journal-title":"Q. J. Med."},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0060","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0165-5728(96)00008-2","article-title":"Polymorphic amino acid domains of the HLA-DQ molecule are associated with disease heterogeneity in myasthenia gravis","volume":"65","author":"Hjelmstrom","year":"1996","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0055","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0165-5728(97)00266-X","article-title":"Structural differences between HLA-DQ molecules associated with myasthenia gravis characterized by molecular modeling","volume":"85","author":"Hjelmstrom","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0065","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.4049\/jimmunol.152.6.3152","article-title":"Major histocompatibility complex class II gene disruption prevents experimental autoimmune myasthenia gravis","volume":"152","author":"Kaul","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jns.2003.09.016","article-title":"Treatment and outcome of myasthenia gravis: retrospective multi-center analysis of 470 Japanese patients, 1999\u20132000","volume":"224","author":"Kawaguchi","year":"2004","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0075","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1034\/j.1399-0039.2003.00103.x","article-title":"New HLA haplotype frequency reference standards: high-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans","volume":"62","author":"Klitz","year":"2003","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0080","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1146\/annurev.immunol.21.090501.080116","article-title":"Genomic organization of the mammalian MHC","volume":"21","author":"Kumanovics","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0085","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awn092","article-title":"IgG1 antibodies to acetylcholine receptors in \u2018seronegative\u2019 myasthenia gravis","volume":"131","author":"Leite","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0090","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/WCO.0b013e3282f4098e","article-title":"Ocular myasthenia: diagnostic and treatment recommendations and the evidence base","volume":"21","author":"Luchanok","year":"2008","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0095","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1172\/JCI114724","article-title":"HLA antigens in Japanese patients with myasthenia gravis","volume":"86","author":"Matsuki","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0100","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0105","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jneuroim.2010.10.020","article-title":"Clinical and biological heterogeneity of autoimmune myasthenia gravis","volume":"231","author":"Pal","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0110","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1600-065X.1999.tb01398.x","article-title":"The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases","volume":"167","author":"Price","year":"1999","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0115","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1749-6632.1998.tb10947.x","article-title":"Susceptibility of HLA DR3 transgenic mice to experimental autoimmune myasthenia gravis","volume":"841","author":"Raju","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0120","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.humimm.2006.02.039","article-title":"HLA-DQ polymorphism in Turkish patients with myasthenia gravis","volume":"67","author":"Saruhan-Direskeneli","year":"2006","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0125","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clim.2003.10.004","article-title":"A variant of childhood-onset myasthenia gravis: HLA typing and clinical characteristics in Japan","volume":"110","author":"Shinomiya","year":"2004","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0130","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1399-0039.2007.00932.x","article-title":"HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China","volume":"70","author":"Trachtenberg","year":"2007","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0135","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nri916","article-title":"Unravelling the pathogenesis of myasthenia gravis","volume":"2","author":"Vincent","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0140","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.humimm.2006.01.002","article-title":"Sequence-based typing of the complete coding sequence of DQA1 and phenotype frequencies in the Dutch Caucasian population","volume":"67","author":"Voorter","year":"2006","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0145","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/clin.1997.4451","article-title":"How subtle differences in MHC class II affect the severity of experimental myasthenia gravis","volume":"86","author":"Yang","year":"1998","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0155","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/j.1365-4632.2004.02389.x","article-title":"Association of HLA-DQA1 and DQB1 genes with vitiligo in Chinese Hans","volume":"44","author":"Yang","year":"2005","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0150","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2011.08.023","article-title":"The association of HLA-DQA1*0401 and DQB1*0604 with thymomatous myasthenia gravis in northern Chinese patients","volume":"312","author":"Yang","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0160","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/jnnp.2006.100545","article-title":"Clinical and serological study of myasthenia gravis in HuBei Province, China","volume":"78","author":"Zhang","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2012.03.018_bb0165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1399-0039.2005.00418.x","article-title":"Polymorphism of human leukocyte antigen-DRB1, -DQB1, and -DPB1 genes of Shandong Han population in China","volume":"66","author":"Zhou","year":"2005","journal-title":"Tissue Antigens"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572812000823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572812000823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:18:44Z","timestamp":1759047524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572812000823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":33,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0165572812000823"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2012.03.018","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HLA-DQA1*03:02\/DQB1*03:03:02 is strongly associated with susceptibility to childhood-onset ocular myasthenia gravis in Southern Han Chinese","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2012.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}